Establishment of an orthotopic transplantable gastric cancer animal model for studying the immunological effects of new cancer therapeutic modules

Molecular Carcinogenesis

Volumn 50, Issue 10, 2011, Pages 739-750

  Shan, Yan Shen ^a   Fang, Jung Hua ^b   Lai, Ming Derg ^b   Yen, Meng Chi ^b   Lin, Pin Wen ^a   Hsu, Hui Ping ^a   Lin, Chian Yuh ^c   Chen, Yi Ling ^c  

^a NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^c CHIA NAN UNIVERSITY OF PHARMACY AND SCIENCE   (Taiwan)

Author keywords

Gastric cancer; Histone deacetylase inhibitors; Immunotherapy; Sodium butyrate; Valproic acid

Indexed keywords

BUTYRIC ACID; CYCLIN E; HERMES ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MUCIN 1; MUCIN 2; MUCIN 5AC; SCATTER FACTOR RECEPTOR; VALPROIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CANCER MODEL; CARCINOMA CELL; CD8+ T LYMPHOCYTE; CELL STRUCTURE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; FEMALE; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; INSTITUTE FOR CANCER RESEARCH MOUSE; LYMPHOCYTIC INFILTRATION; MOUSE; MOUSE GASTRIC CARCINOMA CELL LINE 3I; NEUTROPHIL CHEMOTAXIS; NONHUMAN; ONCOGENE; ONCOGENE C MYC; ORTHOTOPIC TRANSPLANTATION; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STOMACH CANCER; TUMOR REGRESSION;

ANIMALS; BLOTTING, WESTERN; BUTYRATES; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE, TUMOR; CYCLIN E; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTONE DEACETYLASE INHIBITORS; HUMANS; MICE; MICE, INBRED ICR; MICE, INBRED NOD; MICE, SCID; MUCIN-2; NEOPLASM TRANSPLANTATION; NEUTROPHIL INFILTRATION; NIH 3T3 CELLS; ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MYC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STOMACH NEOPLASMS; VALPROIC ACID;

ANIMALIA; MUS;

EID: 80052290886     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.20668     Document Type: Article

References (36)

1. Motoyama T, Hojo H, Watanabe H. Comparison of seven cell lines derived from human gastric carcinomas. Acta Pathol Jpn 1986; 36: 65-83.
2. Sekiguchi M, Sakakibara K, Fujii G. Establishment of cultured cell lines derived from a human gastric carcinoma. Jpn J Exp Med 1978; 48: 61-68.
3. Yanagihara K, Seyama T, Tsumuraya M, Kamada N, Yokoro K. Establishment and characterization of human signet ring cell gastric carcinoma cell lines with amplification of the c-myc oncogene. Cancer Res 1991; 51: 381-386.
4. Yokozaki H. Molecular characteristics of eight gastric cancer cell lines established in Japan. Pathol Int 2000; 50: 767-777.
5. Yasui W, Oue N, Aung PP, Matsumura S, Shutoh M, Nakayama H. Molecular-pathological prognostic factors of gastric cancer: A review. Gastric Cancer 2005; 8: 86-94.
6. Takaishi S, Okumura T, Tu S, et al. Identification of gastric cancer stem cells using the cell surface marker CD44. Stem Cells 2009; 27: 1006-1020.
7. McIntyre A, Gibson PR, Young GP. Butyrate production from dietary fibre and protection against large bowel cancer in a rat model. Gut 1993; 34: 386-391.
8. Singh B, Halestrap AP, Paraskeva C. Butyrate can act as a stimulator of growth or inducer of apoptosis in human colonic epithelial cell lines depending on the presence of alternative energy sources. Carcinogenesis 1997; 18: 1265-1270.
9. Barnard JA, Warwick G. Butyrate rapidly induces growth inhibition and differentiation in HT-29 cells. Cell Growth Differ 1993; 4: 495-501.
10. Hague A, Manning AM, Hanlon KA, Huschtscha LI, Hart D, Paraskeva C. Sodium butyrate induces apoptosis in human colonic tumour cell lines in a p53-independent pathway: Implications for the possible role of dietary fibre in the prevention of large-bowel cancer. Int J Cancer 1993; 55: 498-505.
11. Ogawa H, Rafiee P, Fisher PJ, Johnson NA, Otterson MF, Binion DG. Sodium butyrate inhibits angiogenesis of human intestinal microvascular endothelial cells through COX-2 inhibition. FEBS Lett 2003; 554: 88-94.
12. Tsai LC, Hung MW, Chang GG, Chang TC. Apoptosis induced by the sodium butyrate in human gastric cancer TMK-1 cells. Anticancer Res 2000; 20: 2441-2448.
13. Litvak DA, Hwang KO, Evers BM, Townsend CM, Jr. Induction of apoptosis in human gastric cancer by sodium butyrate. Anticancer Res 2000; 20: 779-784.
14. Takimoto R, Kato J, Terui T, et al. Augmentation of antitumor effects of p53 gene therapy by combination with HDAC inhibitor. Cancer Biol Ther 2005; 4: 421-428.
15. Deshpande SS, Ingle AD, Maru GB. Inhibitory effects of curcumin-free aqueous turmeric extract on benzo[a]pyrene-induced forestomach papillomas in mice. Cancer Lett 1997; 118: 79-85.
16. Fahey JW, Haristoy X, Dolan PM, et al. Sulforaphane inhibits extracellular, intracellular, and antibiotic-resistant strains of Helicobacter pylori and prevents benzo[a]pyrene-induced stomach tumors. Proc Natl Acad Sci USA 2002; 99: 7610-7615.
17. Ichinose M, Nakanishi H, Fujino S, Tatematsu M. Establishment and characterization of two cell lines from N-methyl-N-nitrosourea-induced mouse glandular stomach carcinomas. Jpn J Cancer Res 1998; 89: 516-524.
18. Chen YL, Fang JH, Lai MD, Shan YS. Depletion of CD4(+)CD25(+) regulatory T cells can promote local immunity to suppress tumor growth in benzo[a]pyrene-induced forestomach carcinoma. World J Gastroenterol 2008; 14: 5797-5809.
19. Kao WW, Prockop DJ. Proline analogue removes fibroblasts from cultured mixed cell populations. Nature 1977; 266: 63-64.
20. Chen YL, Wang JY, Chen SH, Yang BC. Granulocytes mediates the Fas-L-associated apoptosis during lung metastasis of melanoma that determines the metastatic behaviour. Br J Cancer 2002; 87: 359-365.
21. Chen YL, Chen SH, Wang JY, Yang BC. Fas ligand on tumor cells mediates inactivation of neutrophils. J Immunol 2003; 171: 1183-1191.
22. Okamoto T, Gohil K, Finkelstein EI, Bove P, Akaike T, van der Vliet A. Multiple contributing roles for NOS2 in LPS-induced acute airway inflammation in mice. Am J Physiol Lung Cell Mol Physiol 2004; 286: L198-L209.
23. Matsuura M, Okazaki K, Nishio A, et al. Therapeutic effects of rectal administration of basic fibroblast growth factor on experimental murine colitis. Gastroenterology 2005; 128: 975-986.
24. Sternberg LR, Byrd JC, Yunker CK, Dudas S, Hoon VK, Bresalier RS. Liver colonization by human colon cancer cells is reduced by antisense inhibition of MUC2 mucin synthesis. Gastroenterology 1999; 116: 363-371.
25. Reis CA, David L, Seixas M, Burchell J, Sobrinho-Simoes M. Expression of fully and under-glycosylated forms of MUC1 mucin in gastric carcinoma. Int J Cancer 1998; 79: 402-410.
26. Reis CA, David L, Nielsen PA, et al. Immunohistochemical study of MUC5AC expression in human gastric carcinomas using a novel monoclonal antibody. Int J Cancer 1997; 74: 112-121.
27. Kim SM, Kim R, Ryu JH, et al. Multinuclear giant cell formation is enhanced by downregulation of Wnt signaling in gastric cancer cell line, AGS. Exp Cell Res 2005; 308: 18-28.
28. Oshima H, Matsunaga A, Fujimura T, Tsukamoto T, Taketo MM, Oshima M. Carcinogenesis in mouse stomach by simultaneous activation of the Wnt signaling and prostaglandin E2 pathway. Gastroenterology 2006; 131: 1086-1095.
29. Kuniyasu H, Yasui W, Yokozaki H, Kitadai Y, Tahara E. Aberrant expression of c-met mRNA in human gastric carcinomas. Int J Cancer 1993; 55: 72-75.
30. Akama Y, Yasui W, Yokozaki H, et al. Frequent amplification of the cyclin E gene in human gastric carcinomas. Jpn J Cancer Res 1995; 86: 617-621.
31. Ho SB, Shekels LL, Toribara NW, et al. Mucin gene expression in normal, preneoplastic, and neoplastic human gastric epithelium. Cancer Res 1995; 55: 2681-2690.
32. Uefuji K, Ichikura T, Mochizuki H. Expression of cyclooxygenase-2 in human gastric adenomas and adenocarcinomas. J Surg Oncol 2001; 76: 26-30.
33. Damia G, D'Incalci M. Contemporary pre-clinical development of anticancer agents-What are the optimal preclinical models? Eur J Cancer 2009; 45: 2768-2781.
34. Hickman JA, Stevens MF, Gibson NW, et al. Experimental antitumor activity against murine tumor model systems of 8-carbamoyl-3-(2-chloroethyl)imidazo[5, 1-d]-1, 2, 3, 5-tetrazin-4(3 H)-one (mitozolomide), a novel broad-spectrum agent. Cancer Res 1985; 45: 3008-3013.
35. Magner WJ, Kazim AL, Stewart C, et al. Activation of MHC class I, II, and CD40 gene expression by histone deacetylase inhibitors. J Immunol 2000; 165: 7017-7024.
36. von Leoprechting A, van der Bruggen P, Pahl HL, Aruffo A, Simon JC. Stimulation of CD40 on immunogenic human malignant melanomas augments their cytotoxic T lymphocyte-mediated lysis and induces apoptosis. Cancer Res 1999; 59: 1287-1294.